PETS
Petmed Express Inc
Going-concern doubt
— cleared Jun 2, 2026
The latest filing states the doubt was alleviated.
“The Company’s liquidity position at March 31, 2026 has been impacted by declining cash balances, declining net sales, recurring operating losses and for fiscal 2026, negative operating cash flows. When considered in the aggregate, these conditions raised substantial doubt about the Company's ability to continue as a going concern within the assessment period, defined as twelve months after the date that our consolidated financial statements are issued. Management evaluated the significance of these conditions in relation to the Company’s ability to meet its obligations within the assessment period and has developed a plan intended to alleviate substantial doubt. The primary elements of the plan include, among other things, advertising and media spend optimization, strategic reductions in operating expenses, including decreases in professional fees following the resolution of non-recurring matters, and reductions in capital expenditures. Management determined that these plans are probable of being effectively implemented and are probable of mitigating the conditions that raised substantial doubt and has concluded that substantial doubt about the Company’s ability to continue as a going concern for the twelve-month period following issuance of these consolidated financial statements has been alleviated.”View the 10-K filed Jun 2, 2026
Company with tickers: PETS
CIK
1040130
CUSIP
716382106
Shares Outstanding
21,365,782
Website
https://petmeds.com
Investor Relations
https://investors.petmeds.com/overview/default.aspx
13F Activity (30d)
17 filings
17 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$110,000,000
as of 2023-03-31
· not restated in filings since 2024-04-15
Remaining Authorization
$28,700,000
as of 2023-12-31
· not restated in filings since 2024-04-15
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-03-31 | $0 | 10-K, filed 2022-05-24 |
| 2021-03-31 | $0 | 10-K, filed 2022-05-24 |
| 2020-03-31 | $11,497,000 | 10-K, filed 2022-05-24 |
| 2019-03-31 | $0 | 10-K, filed 2021-05-25 |
| 2013-03-31 | $3,865,000 | 10-K, filed 2015-05-22 |
| 2012-03-31 | $23,685,000 | 10-K, filed 2014-05-27 |
| 2011-03-31 | $12,247,000 | 10-K, filed 2013-05-28 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2021-03-31 | $0 Δ | 10-K, filed 2022-05-24 |
| 2020-12-31 | $0 Δ | 10-Q, filed 2021-01-26 |
| 2020-09-30 | $0 Δ | 10-Q, filed 2020-11-03 |
| 2020-06-30 | $0 | 10-Q, filed 2020-08-03 |
| 2020-03-31 | $1,000 Δ | 10-K, filed 2022-05-24 |
| 2019-12-31 | $0 Δ | 10-Q, filed 2021-01-26 |
| 2019-09-30 | $0 Δ | 10-Q, filed 2020-11-03 |
| 2019-06-30 | $11,496,000 | 10-Q, filed 2020-08-03 |
| 2013-03-31 | $0 Δ | 10-K, filed 2015-05-22 |
| 2012-12-31 | $0 Δ | 10-Q, filed 2014-01-31 |
| 2012-03-31 | $0 Δ | 10-K, filed 2014-05-27 |
| 2011-12-31 | $1,043,000 Δ | 10-Q, filed 2013-01-29 |